Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
07/21/2017 07/24/2017 07/25/2017 07/26/2017 07/27/2017 Date
2522(c) 2592.7(c) 2500.05(c) 2486(c) 2460(c) Last
11 155 6 207 30 686 8 295 8 974 Volume
-1.29% +2.80% -3.57% -0.56% -1.05% Change
More quotes
Financials ( INR)
Sales 2018 32 628 M
EBIT 2018 5 255 M
Net income 2018 3 897 M
Finance 2018 6 371 M
Yield 2018 1,97%
Sales 2019 36 619 M
EBIT 2019 6 178 M
Net income 2019 4 616 M
Finance 2019 7 826 M
Yield 2019 2,06%
P/E ratio 2018 54,18
P/E ratio 2019 45,75
EV / Sales2018 6,27x
EV / Sales2019 5,55x
Capitalization 211 067 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
07/26 GLAXOSMITHKLINE : Glaxo reports 2Q loss
07/26 GLAXOSMITHKLINE PHARMACEUTICALS : Q1 NET PROFIT DIVES 63% TO Rs26 CRORE
07/26 GLAXOSMITHKLINE PHARMACEUTICALS : Q1 performance temporarily impacted by GST tra..
07/20 GLAXOSMITHKLINE : will cut 320 jobs, none in Philadelphia or the U.S.
07/19 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo to axe 320 UK jobs in manufacturing shak..
07/14 GLAXOSMITHKLINE PHARMACEUTICALS LIMI : ex-dividend day for annual dividend
07/10 GLAXOSMITHKLINE PHARMACEUTICALS : GSK PHARMA TO INVEST Rs1,000 CRORE IN KARNATAK..
07/02 GLAXOSMITHKLINE PHARMACEUTICALS : Trailing twelve month results - glaxosmithklin..
06/30 GLAXOSMITHKLINE PHARMACEUTICALS : Quarterly results - glaxosmithkline pharmaceut..
06/24 GLAXOSMITHKLINE PHARMACEUTICALS : With GlaxoSmithKline eager for marketing appro..
More news
Sector news : Pharmaceuticals - NEC
07/27 S&P 500 declines with transports; oil extends recent rally
07/27DJADRs End Mostly Lower; Anheuser-Busch InBev, AstraZeneca Trade Actively
07/27 AstraZeneca pain weighs on FTSE, Diageo makes merry after results
07/27 AstraZeneca lung cancer failure sparks 16 percent share fall
07/27DJASTRAZENECA : Shares Dive After Major Setback Over Cancer Drugs -- 3rd Update
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/02GlaxoSmithKline Pharmaceuticals : ARMMAN wins share of GSK and Save the Child.. 
04/23Nigerian researchers win GSK’s Open Lab Research Grants: GlaxoSmithKline Phar.. 
2016#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Apr 2016 growth p.. 
2015#Indian #stocks: #Merger #Acquisition: Glaxosmithkline Pharmaceuticals : spar.. 
2015#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Sep 2015 growth p.. 
More tweets
Qtime:5
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Technical analysis trends GLAXOSMITHKLINE PHARMACEUT
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 2 618  INR
Spread / Average Target 5,1%
EPS Revisions
Managers
NameTitle
Annaswamy Vaidheesh Managing Director & Executive Director
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-8.94%3 292
JOHNSON & JOHNSON14.47%352 757
NOVARTIS7.69%222 032
ROCHE HOLDING LTD.4.08%220 038
PFIZER1.91%195 864
MERCK AND COMPANY4.98%169 033